|
시장보고서
상품코드
2052461
마이코플라스마 검사 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Mycoplasma Testing Market, By Product Type, By Application, By End User, By Geography |
||||||
마이코플라스마 검사 시장은 2026년에 11억 80만 달러로 추정되며, 2033년에 21억 5,880만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 10.1%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 11억 80만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 10.10% | 2033년 시장 규모 예측: | 21억 5,880만 달러 |
마이코플라스마 검사는 생명공학 및 제약 분야에서 필수적입니다. 시장에는 마이코플라스마 검사를 위한 다양한 제품이 판매되고 있습니다. 주요 제품은 키트와 서비스 두 가지 유형으로 분류됩니다.
이 키트는 연구자가 직접 마이코플라스마 오염을 검사할 수 있도록 설계된 모든 것을 갖춘 도구입니다. 이 키트에는 검사를 수행하는 데 필요한 모든 시약과 설명서가 포함되어 있습니다. 가장 일반적인 키트 유형으로는 중합효소 연쇄 반응(PCR) 베이스 키트, 효소면역측정법(ELISA) 베이스 키트, 미생물학적 검사 베이스 키트를 들 수 있습니다. PCR 키트는 민감도와 특이도가 높지만 전용 장비가 필요합니다. ELISA 키트는 전용 장비가 필요하지 않아 사용이 편리하지만, PCR에 비해 민감도가 낮습니다. 미생물학적 키트는 마이코플라스마의 증식을 직접 검출하는 것으로, 결과가 나오기까지 시간이 걸립니다.
키트 외에도 많은 기업들이 마이코플라스마 검사 위탁 서비스를 제공하고 있으며, 연구자들은 전문 검사 기관에 검체를 보낼 수 있습니다. 이 서비스의 장점은 연구자가 장비에 대한 투자나 교육을 할 필요가 없다는 것입니다. 검사시설의 숙련된 기술자가 PCR, ELISA, 미생물학적 검사 등 다양한 유형의 검사를 실시하고 보고서를 작성합니다. 단, 검체 운송이 필요하기 때문에 결과가 나오기까지 시간이 걸릴 수 있습니다. 키트는 더 빠른 검사가 가능하지만, 적절한 인프라가 필요합니다. 두 제품 모두 개별 실험실의 요구 사항과 능력에 따라 상황에 따라 각각의 장점이 있습니다.
시장 역학
시장 진입 기업들의 연구개발(R&D) 활동 확대가 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 또한, 시장 진입 기업들의 유기적 및 무기적 전략의 증가도 예측 기간 동안 시장 성장에 기여할 것으로 보입니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 마이코플라스마 검사 시장의 주요 기업 프로파일을 프로파일링합니다. 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계 마이코플라스마 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 마이코플라스마 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 마이코플라스마 검사 시장 : 제품 유형별, 2021-2033년
제5장 세계의 마이코플라스마 검사 시장 : 용도별, 2021-2033년
제6장 세계의 마이코플라스마 검사 시장 : 최종사용자별, 2021-2033년
제7장 세계의 마이코플라스마 검사 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.16Mycoplasma Testing Market is estimated to be valued at USD 1100.8 Mn in 2026 and is expected to reach USD 2,158.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1100.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.10% | 2033 Value Projection: | USD 2,158.8 Mn |
Mycoplasma testing is essential in the field of biotechnology and pharmaceuticals. There are different types of products available in the market for mycoplasma testing. The major products can be categorized into two types - kits and services.
Kits are self-contained tools that allow researchers to test for mycoplasma contamination on their own. These kits have all the necessary reagents and instructions to perform the test. The most common types of kits are polymerase chain reaction (PCR)-based kits, enzyme-linked immunosorbent assay (ELISA) based kits, and microbiological-based kits. PCR kits are highly sensitive and specific but require specialized equipment. ELISA kits are easier to use as they don't need specialized equipment but are less sensitive than PCR. Microbiological kits involve detecting mycoplasma growth directly but take longer time to give results.
Along with kits, various companies offer mycoplasma testing as services where researchers can send their samples to specialized testing facilities. The advantage of services is that researchers do not need to invest in equipment or training. Experienced technicians at the service facilities perform different types of tests like PCR, ELISA, and microbiological assays and provide reports. However, there can be delays in getting results as samples need to be shipped. Kits allow for faster testing but require proper infrastructure. Both products have their advantages in different situations depending on individual lab requirements and capacities.
Market Dynamics
Growing research and development (R&D) activities by the market players is expected drive the market growth over the forecast period. Moreover, increasing organic and inorganic strategies by the market players will aid in the market growth over the forecast period.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global mycoplasma testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Charles River Laboratories International, Merck KGaA, Lonza Group Ltd, Roche Diagnostics, Thermo Fisher Scientific, Merck, InvivoGen, Creative Bioarray, and Other Prominent Players.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global mycoplasma testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mycoplasma testing market.
Market Segmentation
- By Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Kits & Reagents
- Instruments
- By Application Insights (Revenue, USD Mn, 2021 - 2033)
- Cell Line Testing
- Virus Testing
- End of Production Testing
- Others (Raw Material Testing, etc.)
- By End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic Research Institutes
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Charles River Laboratories International
- Merck KGaA
- Lonza Group Ltd.
- Roche Diagnostics
- Thermo Fisher Scientific
- Merck
- InvivoGen
- Creative Bioarray
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing demand for high-quality biopharmaceutical products
- Rising adoption of advanced molecular testing
- Key Highlights
- Regulatory Scenario
- Recent Trends
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Mycoplasma Testing Market, By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Mycoplasma Testing Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cell Line Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Virus Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- End of Production Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Raw Material Testing, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Mycoplasma Testing Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Academic Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Mycoplasma Testing Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033(%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profile
- Charles River Laboratories International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
- InvivoGen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Creative Bioarray
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Charles River Laboratories International
- Analyst Views
9. Section
- References
- Research Methodology
- About us
